BeOne Medicines
ONC
#772
Rank
C$44.41 B
Marketcap
C$428.08
Share price
0.20%
Change (1 day)
30.76%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Financial Statements

Thumbnail BeOne Medicines Financial Statement 2025

Financial Statement 2025

Language: English

View Financial Statement